HIV and Aging in the Era of ART and COVID-19: Symposium Overview.

Antiretroviral therapy (ART) has altered the clinical environment of HIV, shifting the traditional focus on AIDS-induced opportunistic infections and cancers to one in which the most common morbidities and causes of death differ little from those seen in noninfected adults. The primary distinction is that these conditions, which include cardiovascular diseases, declining physical function, neurocognitive and neuropsychiatric disorders, and alterations in body composition, first manifest in people living with HIV (PLWH) approximately 5-10 years earlier than HIV-uninfected individuals.(1-3) The accelerated aging in HIV has now been further complicated by the emergence of SARSCoV-2 infection and postacute COVID syndrome (PACS). Exploring the linkages-and points of difference-between these 2 viral conditions, while promoting multidisciplinary collaboration among researchers to identify new perspectives on HIV and aging, was the aim of "HIV and Aging in the Era of ART and COVID-19 inter-CFAR symposium."